|

Skarpaas, Tone (1); Sundøy, Anders (2); Bruu, Anne-Lise (3); Vene,
Sirkka (4); Pedersen, Judith (1); Eng, Per Gunnar (5); Csángó, Péter A
(1)
(1) Dept Clinical Microbiology, Vest-Agder Central Hospital,
Kristiansand, Norway;
(2) Dept Internal Medicine (Inf.), Vest-Agder
Central Hospital;
(3) Dept Virology, National Institute Public Health,
Oslo;
(4) Dept Virology, Swedish Institute for Infectious Disease Control
(SMI);
(5) Chief medical officer, Tromøy, Norway.
E-mail: tone.skarpaas@vas.no
Introduction
The first reported patient with tick-borne encephalitis (TBE) in Norway
became ill in 1998 and the second patient had TBE in the autumn 1999. Both
had visited the island Tromøy, Aust-Agder county as tourists preceding
their disease (1,2). Subsequently, we intensified the search for TBE
antibodies in cases of encephalitis. Seroprevalence studies were carried
out in our district.
Material and methods
Sera from persons with encephalitis were tested for TBEV IgM and IgG
antibodies with EIA tests (Enzygnost, Dade Behring; µ-capture IgM, SMI;
Progene Immunozyme IgG) and a neutralization test. In 1999 we studied 98
sera positive for Borrelia antibodies from persons in Aust- and Vest-Agder
counties with regard to TBEV IgG antibodies (3). In 2000 we studied 126
stored specimens from 1997–2000 of persons living on Tromøy for TBEV
IgG antibodies.
Results
We report 3 new cases of TBE: 2 had encephalitis in Sep–Oct 2000. The
3rd patient, with antibodies to TBEV found by retrospective testing, had
the disease in Aug 1997. This is probably the first reported case of TBE
in Norway.
None of the three patients had been outside the country in the weeks
preceding disease. Summary of clinical pictures: Age 42-67 years.
Prodromal phase with fever, headache and muscle pain. Manifestation phase
with fever, headache, nausea and vomiting. One person had visual
disturbances, another had reduced consciousness. 2 out of three were
hospitalized. All three patients recovered after 4–6 weeks.
Summary of laboratory parameters
Serum: CRP 10–30 mg/l, moderate leucocytosis, neg. for antibodies to
Mycoplasma pneumoniae, antibodies to B.burgdorferi in low titers in one
patient. TBEV IgM and IgG detected, rise in titer with neutralization
test. CSF (2 patients): leucocytes 29–39x106/l, protein 610–625
mg/l, PCR neg. for entero-, VZV and HSV. Retrospective study of sera from
1997–2000 of persons from Tromøy showed the presence of IgG to TBEV in
3 of 126 (2,4%), while in 1999, IgG antibodies to TBEV were found in 0,3–0,4
% of persons mainly from other areas of the Agder counties (3).
Conclusions
Three new cases of TBE from persons living in Aust- and Vest-Agder
counties are reported. This study reports the first TBE case diagnosed in
Norway, in a person living on Tromøy who had the disease in August 1997.
Four out of the first 5 Norwegian cases with TBE visited Tromøy the last
few weeks before falling ill, 3 as tourists. Our seroprevalence studies
indicate that Tromøy may have a higher incidence of TBE than the rest of
Aust- and Vest-Agder counties. Our results confirm that TBE occurs in the
coastal area of southern Norway.
References
-
Blystad H, Bruu AL, Mehl R, Moen EW. Første meldte tilfellet
av sannsynlig innenlandsk smittet skogflåttencefalitt (TBE) i Norge.
MSIS 1999; 27: 17.
-
Ormaasen V, Brantsæter AB, Moen EW. Tick-borne encephalitis
in Norway. Tidsskr Nor Lægeforen 2001; 121: 807-9
-
Skarpaas T, Csángó P, Pedersen J. Skogflåttencefalitt
(TBE) på sørlandet. MSIS 2000; 28:09.
|
Feedback And Comments
|
Please enter a comment or feedback.
|
|
|
CRTBI - Extended Abstracts
Bunikis J et al.: Structure and Function of the Surface Proteins of Borrelia Spirochetes
Dambrauskienè V et al.: Epidemiology of Tick-Born Encephalitis and it's Clinical Manifestations in
Panevèzys City County
Egenvall A et al.: A serosurvey of granulocytic Ehrlicha spp. and Borrelia burgdorferi sensu lato
in 2018 Swedish horses
Gray J S et al.: The biology of Ixodes ticks, with special reference to Ixodes ricinus
Guillaume B et al.: Human Granulocytic Ehrlichia Infection in Belgium
Haglund M et al.: Tick-borne encephalitis (TBE) - an overview
Larsen K et al.: Tick species and arthropod-transmitted infections from Danish cats and dogs
Lundkvist Å et al.: Characterization of Tick-borne enchephalitis virus from Latvia – evidence for co-circulation of three distinct subtypes
Malmgren L et al.: A field trial of the effectiveness of 65% permetrin spot-on and 9.7% fipronil spot-on against ticks (Ixodes ricinus) on dogs
Massung R F et al.: Genetic Variants of Ehrlichia phagocytophila in the United States
Nilsson I et al.: Serological evidence of Lyme arthritis in Egypt
Nyman D et al.: Ticks have preferences in choosing human hosts
Ornstein K et al.: Quantification of spirochete burden in Borrelia burgdorferi infected ticks fed on OspA immunized mice by 16S rRNA RT real-time PCR
Randolph S et al.: Epidemiological consequences of tick ecology
Skarpaas T et al.: Tick-borne encephalitis in Norway
Soutschek E et al.: A defined mixture of recombinant antigens from several Borrelia genospecies improves serodiagnosis of Lyme disease
von Stedingk L V et al.: Recent research on human babesiosis – the Scandinavian perspective
Stuen S et al.: Granulocytic Ehrlichia infection in domestic and wild ruminants in Norway
Widhe M et al.: Cytokines in Lyme Borreliosis: in vivo levels of TGF-b1, TNF-a and IL-6 in serum and cerebrospinal fluid from patients with neuroborreliosis or erythema migrans in relation to clinical outcome |